$INMD Balance Sheet | Understand Stock

$INMD

$13.58 -$0.14 (1.02%) Close

$INMD Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated balance sheets

In millions of USD, except per-share amounts

	Q4 FY2025 As of Dec 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q4 FY2020 As of Dec 31, 2020	Q4 FY2019 As of Dec 31, 2019
Assets
CURRENT ASSETS:
Cash and cash equivalents
Marketable securities (amortized cost of $83,542 and $268,129, as of December 31, 2025 and 2024, respectively)
Short-term bank deposits
Accounts receivable, net of allowance for credit losses of $2,371 and $1,825, as of December 31, 2025, and 2024, respectively
Prepaid expenses and other receivables
Inventories
TOTAL CURRENT ASSETS
NON-CURRENT ASSETS:
Accounts receivable net of allowance for credit losses of $856 and $924 as of December 31, 2025, and 2024, respectively
Other receivables
Deferred income tax assets
Operating lease right-of-use assets
Property and equipment, net
Other investments
TOTAL NON-CURRENT ASSETS
TOTAL ASSETS

Liabilities and shareholders’ equity
CURRENT LIABILITIES:
Accounts payables
Contract liabilities
Other liabilities
TOTAL CURRENT LIABILITIES
NON-CURRENT LIABILITIES:
Contract liabilities
Other liabilities
Operating lease liabilities
Deferred income taxes, net
TOTAL NON-CURRENT LIABILITIES
TOTAL LIABILITIES

SHAREHOLDERS’ EQUITY:
Ordinary shares, NIS 0.01 par value, authorized 200,000,000 shares at December 31, 2025, and 2024 Issued 88,333,753 and 87,583,673 shares at December 31, 2025 and 2024, respectively Outstanding 63,358,750 and 69,558,670 shares at December 31, 2025 and 2024, respectively
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Less treasury shares, at cost: 24,975,003 and 18,025,003 ordinary shares at December 31, 2025 and 2024, respectively
TOTAL SHAREHOLDERS’ EQUITY
Non-controlling interests
TOTAL SHAREHOLDERS' EQUITY

TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

Comments